tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
MCRB is currently covered by 8 analysts with an average price target of $8.63. This is a potential upside of $7.71 (838.04%) from yesterday's end of day stock price of $0.92.
Seres Therapeutics's activity chart (see below) currently has 49 price targets and 51 ratings on display. The stock rating distribution of MCRB is 94.12% BUY and 5.88% SELL.
Analysts average stock forecasts to be materialized ratio is 37.77% with an average time for these price targets to be met of 78.11 days.
Highest price target for MCRB is $10, Lowest price target is $1.25, average price target is $8.63.
Most recent stock forecast was given by JOHN NEWMAN from CANACCORD on 13-Sep-2024. First documented stock forecast 22-Oct-2015.
Currently out of the existing stock ratings of MCRB, 16 are a BUY (94.12%), 1 are a SELL (5.88%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$10
$8.87 (784.96%)
$10
3 months 8 days ago
(13-Sep-2024)
0/8 (0%)
$9 (900.00%)
Buy
$1.25
$0.12 (10.62%)
$6
4 months 7 days ago
(14-Aug-2024)
0/6 (0%)
$0.35 (38.89%)
Sell
$1.25
$0.12 (10.62%)
$7
1 years 1 months 18 days ago
(03-Nov-2023)
4/4 (100%)
$-0.05 (-3.85%)
99
Buy
$12
$10.87 (961.95%)
$13
1 years 5 months 25 days ago
(26-Jun-2023)
4/11 (36.36%)
$6.6 (122.22%)
281
Buy
$12
$10.87 (961.95%)
$29
1 years 7 months 24 days ago
(27-Apr-2023)
3/4 (75%)
$6.68 (125.56%)
38
What is MCRB (Seres Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on MCRB (Seres Therapeutics) with a proven track record?
Which analyst has the current lower performing score on MCRB (Seres Therapeutics) with a proven track record?
Which analyst has the most public recommendations on MCRB (Seres Therapeutics)?
Which analyst is the currently most bullish on MCRB (Seres Therapeutics)?
Which analyst is the currently most reserved on MCRB (Seres Therapeutics)?
